首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

基因表現分析市場規模、佔有率和成長分析（按產品、製程、產能、技術、應用和地區分類）－產業預測，2026-2033年

市場調查報告書

商品編碼

1897944

基因表現分析市場規模、佔有率和成長分析（按產品、製程、產能、技術、應用和地區分類）－產業預測，2026-2033年

Gene Expression Analysis Market Size, Share, and Growth Analysis, By Product (Reagents & Consumables, Instruments), By Process (Sample Collection, Purification), By Capacity, By Technique, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球基因表現分析市場規模預計在 2024 年達到 52 億美元，從 2025 年的 56.4 億美元成長到 2033 年的 107.5 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

全球基因表現分析市場正經歷顯著擴張，這主要得益於人們對個人化醫療和標靶治療策略日益成長的需求。基因表現分析能夠識別與特定疾病相關的獨特基因特徵，有助於改善治療效果。精準醫療的發展，以及次世代定序和微陣列等高通量平台的進步，透過提供經濟高效且快速的基因譜分析能力，進一步推動了市場成長。此外，癌症和心血管疾病等慢性疾病的快速成長也凸顯了利用基因表現分析發現生物標記和治療標靶的必要性。然而，基因表現分析仍面臨許多挑戰，包括複雜的數據解讀、熟練的生物資訊專業人員短缺、高成本以及確保不同實驗室結果可重複性的標準化需求。解決這些挑戰將有助於推動市場發展和普及應用。

全球基因表現分析市場促進因素

癌症、心血管疾病和神經系統疾病等慢性疾病發生率的不斷上升，顯著增加了對基因表現分析的需求。基因表現分析對於揭示與這些疾病相關的複雜分子機制至關重要，有助於早期診斷、改進治療策略並推動創新藥物的研發。隨著研究人員和醫療保健專業人員尋求更有效的應對這些健康挑戰的方法，理解基因表現模式已成為醫學進步和改善患者預後的關鍵組成部分。隨著醫療保健需求的不斷變化，對先進基因表現分析工具的需求預計將持續成長。

全球基因表現分析市場面臨的限制因素

全球基因表現分析市場面臨許多限制因素，包括倫理考量、隱私問題以及基因組資料使用和保護的監管要求。遵守嚴格的資料隱私法、確保知情同意以及遵循病患資訊管理的倫理通訊協定，對從事該領域的研究人員和公司而言都是巨大的挑戰。這些障礙可能會阻礙創新，延緩新技術的應用，因為相關人員必須在複雜的法律規範下工作，同時也要維護敏感基因資料的完整性和安全性。因此，這些因素可能會限制市場的成長和發展。

全球基因表現分析市場趨勢

由於單細胞基因表現表現分析的興起，全球基因表現分析市場正經歷顯著成長。這一趨勢主要得益於微流體技術、單細胞分離方法和先進定序技術的創新，這些技術能夠實現單細胞層級的深度分析。隨著研究人員致力於識別細胞異質性和稀有細胞群，監測單一細胞內動態基因表現變化的能力正在加深我們對複雜生物過程的理解。對單細胞分析的需求預計將徹底改變基因表現研究及其應用，並對發育生物學、腫瘤學和精準醫學產生重大影響。

Illumina（USA）
Thermo Fisher Scientific（USA）
Bio-Rad Laboratories（USA）
F. Hoffmann-La Roche Ltd（Switzerland）
Pacific Biosciences of California（USA）
BGI（China）
PerkinElmer Inc.（USA）
Agilent Technologies（USA）
Quest Diagnostics（USA）
Promega Corporation（USA）
Luminex Corporation（USA）
Takara Bio（Japan）
Danaher Corporation（USA）
Merck Sharp & Dohme Corp.（USA）
Genotypic Technology Pvt Ltd（India）
Macrogen（South Korea）
Eurofins Scientific（Luxembourg）
SciGenom Labs Pvt. Ltd（India）
Takara Holdings（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35J2096

Global Gene Expression Analysis Market size was valued at USD 5.2 Billion in 2024 and is poised to grow from USD 5.64 Billion in 2025 to USD 10.75 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global gene expression analysis market is witnessing significant expansion, propelled by the rising demand for personalized medicine and targeted treatment strategies. This analysis identifies distinct gene signatures linked to particular diseases, enhancing the effectiveness of therapies. The push towards precision medicine, alongside advancements in high-throughput platforms like next-generation sequencing and microarrays, has further stimulated market growth by providing cost-effective and rapid gene profiling capabilities. Additionally, the surge in chronic diseases, such as cancer and cardiovascular disorders, underscores the necessity of gene expression analysis for discovering biomarkers and therapeutic targets. However, challenges remain, including complex data interpretation, a shortage of skilled bioinformatics professionals, high costs, and the need for standardization to ensure reproducible results across laboratories. Addressing these issues will enhance market dynamics and adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Expression Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Expression Analysis Market Segments Analysis

Global Gene Expression Analysis Market is segmented by Product, Process, Capacity, Technique, Application and region. Based on Product, the market is segmented into Reagents & Consumables, Instruments and Service. Based on Process, the market is segmented into Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation and Others. Based on Capacity, the market is segmented into Low- to Mid- Plex and High-Plex. Based on Technique, the market is segmented into RNA Expression, Promoter Analysis and Protein Expression & Posttranslational Modification Analysis. Based on Application, the market is segmented into Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Expression Analysis Market

The increasing incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders significantly boosts the need for gene expression analysis. This analysis is essential for dissecting the intricate molecular mechanisms associated with these conditions, which in turn facilitates early diagnosis, enhances treatment strategies, and fosters innovative drug discovery. As researchers and healthcare professionals seek more effective ways to combat these health challenges, the pursuit of understanding gene expression patterns becomes a vital component in advancing medical science and improving patient outcomes. Ultimately, the demand for sophisticated gene expression analysis tools continues to grow in light of these evolving healthcare needs.

Restraints in the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market faces several restraints stemming from ethical considerations, privacy issues, and regulatory requirements concerning the use and protection of genomic data. This landscape of compliance with stringent data privacy laws, ensuring informed consent, and adhering to ethical protocols for managing patient information presents significant challenges for researchers and companies operating in this field. These obstacles can hinder innovation and slow the adoption of new technologies, as stakeholders must navigate the complexities of regulatory frameworks while maintaining the integrity and security of sensitive genetic data. Consequently, these factors could potentially limit market growth and development.

Market Trends of the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market is witnessing a notable surge, fueled by the rise of single-cell gene expression analysis. This trend is primarily driven by innovations in microfluidics, single-cell isolation methods, and advanced sequencing technologies, which facilitate detailed profiling at the single-cell level. As researchers increasingly focus on cellular heterogeneity and the identification of rare cell populations, the ability to monitor dynamic gene expression changes within individual cells is enhancing our understanding of complex biological processes. With significant implications for developmental biology, oncology, and precision medicine, the demand for single-cell analysis is set to transform gene expression research and its applications.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Gene Expression Analysis Market Size by Product & CAGR (2026-2033)

Market Overview
Reagents & Consumables
- Assays & kits
- Enzymes
- DNA chips
- Others
Instruments
- PCR
- NGS
- DNA Microarrays
- Others
Service

Global Gene Expression Analysis Market Size by Process & CAGR (2026-2033)

Market Overview
Sample Collection
Purification
cDNA synthesis & conversion
PCR Analysis
Data analysis & interpretation
Others

Global Gene Expression Analysis Market Size by Capacity & CAGR (2026-2033)

Market Overview
Low- to Mid- Plex
High-Plex

Global Gene Expression Analysis Market Size by Technique & CAGR (2026-2033)

Market Overview
RNA Expression
Promoter Analysis
Protein Expression & Posttranslational Modification Analysis

Global Gene Expression Analysis Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery & Development
Clinical Diagnostics
Biotech & Microbiology
Others

Global Gene Expression Analysis Market Size & CAGR (2026-2033)

North America (Product, Process, Capacity, Technique, Application)
- US
- Canada
Europe (Product, Process, Capacity, Technique, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Process, Capacity, Technique, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Process, Capacity, Technique, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Process, Capacity, Technique, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Sharp & Dohme Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genotypic Technology Pvt Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macrogen (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SciGenom Labs Pvt. Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Holdings (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments